![]() |
市场调查报告书
商品编码
1562278
2030 年亚太地区门诊中央履行市场预测 - 区域分析 - 按产品类型和最终用户Asia Pacific Outpatient Central Fulfillment Market Forecast to 2030 - Regional Analysis - by Product Type and End User |
2022年亚太地区门诊中央履行市价为5,060万美元,预计2030年将达到1.2644亿美元;预计2022年至2030年复合年增长率为12.1%。
不断增长的老龄化人口和新兴市场推动亚太地区门诊中央履行市场
人口老化是医疗保健产业进步的关键。因此,预计不断增长的老龄化人口将为药房提供重要的成长机会。根据联合国《2022年世界人口展望》报告,老年人口预计将从2022年占总人口的10%增加到2050年占总人口的16%。增长未来几年的护理和药物。全球预期寿命的激增也导致需要更多数位化和自动化的成人照护系统。自动配药机的发展为已开发地区带来了效益。 LED 显示器、马达控制器和警报系统等先进功能可协助人们进行用药提醒。自动化药房系统将使他们能够更好地追踪药品和库存。此外,实施自动化药局系统引发了成人用药依从性。凭藉这些功能,自动化药局系统的采用预计在未来几年将在日本、印度、韩国和中国等发展中国家成长。
由于医疗保健成本不断上升以及改善药物服务可近性的压力,药品管理在发展中国家至关重要。为了方便取得药品,发展中国家政府正在采取各种策略。由于慢性病盛行率激增、医院越来越多地采用最新医疗技术以及对先进医疗技术的认识不断增强,大多数市场参与者都将注意力集中在中国、印度和阿联酋等新兴市场。
亚太地区门诊中央履行市场概览
中国是亚太地区最大的门诊集中履行市场。中国的「十三五」规划将健康和创新放在首位,增加了对先进医疗设备的需求。此外,老年人口的增加和慢性病的增加也促进了该国门诊中心履行市场的发展。熟练劳动力的供应、低廉的营运成本和巨大的生产空间进一步吸引了市场领导者在中国设立生产工厂。中国与其他国家医疗保健系统的差异导致了中国医疗事故的区域特征。因此,该国的自动化药品配药显着增加,特别是在 COVID-19 大流行期间。 2021年,湖南长沙医院率先安装机器人发药系统,加强药品发药。自动化技术也广泛应用于医疗保健领域,利用了对自动化药局系统的需求。中国是向西方国家最大的活性药物成分出口国,需要对运输产品的包装和标籤进行自动化。生产基地和仓库在生产基地安装了自动化药局系统。
中国的许多新创公司都致力于开发配药技术。例如,COBOT 是一家开发和销售工业机器人智慧系统的新创公司。它开发了下一代智慧配药机器人并将其商业化。它还可以透过药品管理系统自动补充库存。
亚太地区门诊中央履行市场收入及 2030 年预测(百万美元)
亚太地区门诊中央履行市场区隔
亚太地区门诊中央履行市场依据产品类型、最终用户和国家进行细分。根据产品类型,亚太地区门诊中央履行市场分为自动配药系统、自动包装和标籤系统、自动桌面柜檯、自动储存和检索系统等。 2022 年,自动配药系统领域占据最大的市场份额。
就最终用户而言,亚太地区门诊中央履行市场分为医院药局、零售药局和邮购药局。 2022年,医院药局领域占据最大的市场份额。
依国家/地区划分,亚太地区门诊中央履行市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022 年,中国在亚太地区门诊集中履行市场份额中占据主导地位。
贝克顿·迪金森公司;卡普萨解决方案有限责任公司;康德乐 (Cardinal Health) 公司、麦克森公司 (McKesson Corp);和 Omnicell Inc 是亚太地区门诊中心履行市场的一些领先参与者。
The Asia Pacific outpatient central fulfillment market was valued at US$ 50.60 million in 2022 and is expected to reach US$ 126.44 million by 2030; it is estimated to record a CAGR of 12.1% from 2022 to 2030.
Rising Aging Population and Emerging Markets Boosts Asia Pacific Outpatient Central Fulfillment Market
The aging population is a key to advancements in the healthcare sector. Thus, the growing aging population is anticipated to serve vital growth opportunity for the pharmacy. According to the United Nations World Population Prospects 2022 report, the elderly population is projected to increase from 10% of the total population in 2022 to 16% of the total population by 2050. The rapidly growing aging population indicates an exponential rise in demand for elderly care and medicines in the coming years. An upsurge in life expectancy worldwide has also led to the need for more digital and automated systems for adult care. The development of automatic medicine dispensers has served beneficially in developed regions. Advanced features such as an LED display, a motor controller, and an alarm system help people with medication reminders. Automated pharmacy systems would enable them to keep track of their medicine and stocks better. Further, implementing automated pharmacy systems has triggered adult medication adherence. With such features, the adoption of automated pharmacy systems is expected to grow in developing countries such as Japan, India, South Korea, and China in the coming years.
Pharmaceutical management is essential in developing countries owing to rising healthcare costs and pressure to improve access to pharmaceutical services. To ease access to drugs, governments of developing countries are adopting various strategies. Most market players focus on emerging markets such as China, India, and the UAE due to the surging prevalence of chronic diseases, rising adoption of the latest medical technologies in hospitals, and increasing awareness about advanced medical technologies.
Asia Pacific Outpatient Central Fulfillment Market Overview
China is the largest market for outpatient central fulfillment in Asia Pacific. The 13th Five-Year Plan of China that prioritized health and innovation has augmented demand for advanced medical devices. Moreover, the rising geriatric population and increasing chronic health conditions contribute to the outpatient central fulfillment market in this country. The availability of skilled laborers, low cost of operations, and massive space for production have further attracted the market leaders to have their production plants in China. Differences between the healthcare systems in China and other countries result in region-specific patterns of medical malpractice in China. Thus, the country has seen a significant rise in automated pharmaceutical dispensing, especially during the COVID-19 pandemic. In 2021, the Hospital of Changsha in the Hunan province was the first to install robotic pharmacy dispensing systems to enhance drug dispensing. Automation technologies are also widely used in the healthcare sector, leveraging demand for automated pharmacy systems. China is the largest exporter of active pharmaceutical ingredients to Western countries, requiring automation for the packaging and labeling of the products to be shipped. Production sites and warehouses have automated pharmacy systems installed in the manufacturing site.
Many startups in China are engaged in developing technologies for dispensing medicines. For instance, COBOT is a startup company that develops and markets smart systems for industrial robots. It has developed and commercialized a next-generation, smart medicine-dispensing robot. It can also automatically replenish stocks through a drug management system.
Asia Pacific Outpatient Central Fulfillment Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Outpatient Central Fulfillment Market Segmentation
The Asia Pacific outpatient central fulfillment market is segmented based on product type, end user, and country. Based on product type, the Asia Pacific outpatient central fulfillment market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated tabletop counters, automated storage and retrieval systems, and others. The automated medication dispensing systems segment held the largest market share in 2022.
In terms of end user, the Asia Pacific outpatient central fulfillment market is segmented into hospital pharmacies, retail pharmacies, and mail-order pharmacies. The hospital pharmacies segment held the largest market share in 2022.
Based on country, the Asia Pacific outpatient central fulfillment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific outpatient central fulfillment market share in 2022.
Becton Dickinson and Co; Capsa Solutions, LLC; Cardinal Health Inc, McKesson Corp; and Omnicell Inc are some of the leading players operating in the Asia Pacific outpatient central fulfillment market.